Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.12 | 12.1212121212 | 0.99 | 1.11 | 0.9297 | 1202577 | 1.03170356 | CS |
| 4 | 0 | 0 | 1.11 | 1.19 | 0.772 | 1534231 | 0.96059289 | CS |
| 12 | -0.13 | -10.4838709677 | 1.24 | 1.38 | 0.772 | 1100414 | 1.09621074 | CS |
| 26 | 0 | 0 | 1.11 | 1.45 | 0.772 | 830092 | 1.1441181 | CS |
| 52 | 0.08 | 7.76699029126 | 1.03 | 1.72 | 0.4986 | 1100056 | 1.1192784 | CS |
| 156 | -4.49 | -80.1785714286 | 5.6 | 7.4 | 0.4986 | 571620 | 1.51929644 | CS |
| 260 | -2.9 | -72.319201995 | 4.01 | 19.38 | 0.4986 | 730178 | 6.23124834 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
